Related Experiment Video

Updated: Aug 29, 2026

Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay
13:10

Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay

Published on: June 9, 2017

Involvement of protein kinase C-delta in DNA damage-induced apoptosis

Alakananda Basu1

  • 1Department of Molecular Biology & Immunology, University of North Texas Health Science Center, Fort Worth, Texas 76107, USA. abasu@hsc.unt.edu

Journal of Cellular and Molecular Medicine
|February 3, 2004
PubMed

Insights

Protein kinase C delta (PKCdelta) plays a key role in programmed cell death (apoptosis) following DNA damage. Its activation and cellular location influence cancer drug effectiveness and resistance.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Apoptosis, or programmed cell death, is crucial for maintaining cellular homeostasis and preventing diseases like cancer.
  • Dysregulation of apoptosis is linked to cancer development and resistance to anticancer therapies.
  • The protein kinase C (PKC) family, particularly PKCdelta, is implicated in the complex signaling networks governing apoptosis.

Purpose of the Study:

  • To review the current understanding of PKCdelta's role in DNA damage-induced apoptosis.
  • To explore how PKCdelta activation and subcellular localization impact apoptotic pathways.
  • To highlight the significance of PKCdelta in the context of cancer and drug resistance.

Main Methods:

  • Literature review of studies investigating PKCdelta and apoptosis.
  • Analysis of research on PKCdelta's interaction with caspases and its translocation to cellular compartments.
  • Synthesis of findings related to PKCdelta's function in response to DNA damage.

Main Results:

  • PKCdelta acts as a key regulator in DNA damage-induced apoptosis, functioning both upstream and downstream of caspases.
  • Activation of PKCdelta and its translocation to mitochondria and the nucleus are critical for its apoptotic function.
  • PKCdelta's activity influences the efficacy of anticancer drugs and the development of drug resistance.

Conclusions:

  • PKCdelta is a significant mediator of apoptosis following DNA damage.
  • Understanding PKCdelta's intricate role offers potential therapeutic strategies for cancer treatment.
  • Further research into PKCdelta signaling pathways is warranted for developing novel anticancer drugs.

More Related Videos

Visualization of DNA Repair Proteins Interaction by Immunofluorescence07:55

Visualization of DNA Repair Proteins Interaction by Immunofluorescence

Published on: June 26, 2020

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes15:43

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on: January 7, 2013

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...